Ex-Gov. Weld Says Research Key to Pot Legalization
*By Jacqueline Corba*
Former Massachusetts Governor Bill Weld called on President Trump to change the federal classification of marijuana so researchers can explore the drug's ability to treat diseases, including cancer.
"I think anybody who is a reasonable politician has to listen to the argument that its been proved around the world that this will cure the ailments that your constituents are suffering from," Weld said in an interview with Cheddar at the Cannabis World Congress in New York. "Do you want to look your constituents in the eye, and say, 'No ー I'm going to stand in the way of you getting the physical relief from pain and suffering that you know you can get around the corner? That's a position that makes no political sense."
According to the Drug Enforcement Administration, marijuana is a Schedule I drug, which is the same category as heroin, LSD, and ecstasy. This means it is considered to have a high potential for abuse and is not accepted for medical use.
Weld, who is a member of the board of the cannabis company Acreage Holdings, said Washington has yet to catch up with the country when it comes to cannabis: 64 percent of Americans say it should be made legal, according to a [Gallup Poll](http://news.gallup.com/poll/221018/record-high-support-legalizing-marijuana.aspx).
"There's a lot of old people who have pains and aches that cannabis is very useful in just making go away. They are a voting bloc," said Weld, who also said millennial voters are another large bloc in favor of legalization. "So that's a pretty good pair of bookend voting blocs for any politician that is listening."
Weld said ultimately research will make it impossible for members of Congress to vote against cannabis, once they understand more about the drugs abilities.
For the full interview, [click here](https://cheddar.com/videos/why-bill-weld-is-pushing-to-declassify-marijuana-as-schedule-i-drug).
The Biden administration has enacted a new labor rule that aims to prevent the misclassification of workers as independent contractors. The labor department rule going into effect Tuesday replaces a scrapped Trump-era standard that lowered the bar for classifying employees as contractors
The KC-46 was to be the ideal candidate for a fixed-price development program. Instead, it has cost Boeing billions, and made industry wary of such deals.
Dave Long, CEO and Co-Founder of Orangetheory Fitness joins Cheddar to chat trends in the industry for 2024. He updates us on the company's plans to expand and what the state of the economy has meant for business.
One of the world's largest renewable energy developers will be getting hundreds of wind turbines from General Electric spinoff GE Vernova as part of a record equipment order and long-term service deal.
A moon landing attempt by a private US company appears doomed because of a fuel leak on the newly launched spacecraft. Astrobotic Technology managed to orient the lander toward the sun Monday so its solar panel could capture sunlight and charge its onboard battery.
Treasury Secretary Janet Yellen has announced that 100,000 businesses have signed up for a new database that collects ownership information intended to help unmask shell company owners. Yellen says the database will send the message that “the United States is not a haven for dirty money.”
A new version of the federal student aid application known as the FAFSA is available for the 2024-2025 school year, but only on a limited basis as the U.S. Department of Education works on a redesign meant to make it easier to apply.
A steep budget deficit caused by plummeting tax revenues and escalating school voucher costs will be in focus Monday as Democratic Gov. Katie Hobbs and the Republican-controlled Arizona Legislature return for a new session at the state Capitol.
The first U.S. lunar lander in more than 50 years is on its way to the moon. The private lander from Astrobotic Technology blasted off Monday from Cape Canaveral, Florida, catching a ride on United Launch Alliance's brand new rocket Vulcan.